Jahan S. Khalili

2.5k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Jahan S. Khalili is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jahan S. Khalili has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Jahan S. Khalili's work include Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (10 papers) and CAR-T cell therapy research (7 papers). Jahan S. Khalili is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (10 papers) and CAR-T cell therapy research (7 papers). Jahan S. Khalili collaborates with scholars based in United States, Australia and Hungary. Jahan S. Khalili's co-authors include Yongqi Yan, Hai Zhu, Dan R. Littman, Kui Shin Voo, Laura Bover, Biao Zheng, César Boggiano, Shino Hanabuchi, Fabio R. Santori and Yong‐Jun Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jahan S. Khalili

23 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of IL-17-producing FOXP3⁺regulatory T cells in humans

2009 559 citations Kui Shin Voo, Fabio R. Santori et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jahan S. Khalili United States	16	865	448	402	223	148	24	1.7k
Stephanie H. Kim United States	22	532 0.6×	630 1.4×	214 0.5×	57 0.3×	133 0.9×	35	1.4k
Breanna M. Allen United States	8	624 0.7×	660 1.5×	702 1.7×	63 0.3×	38 0.3×	10	1.8k
Yuekang Xu China	25	1.4k 1.7×	629 1.4×	383 1.0×	58 0.3×	16 0.1×	53	2.3k
Barbara P. Vistica United States	22	744 0.9×	352 0.8×	230 0.6×	28 0.1×	277 1.9×	38	1.4k
Arnav Mehta United States	18	751 0.9×	1.1k 2.5×	499 1.2×	125 0.6×	15 0.1×	44	2.3k
Laura S. Angelo United States	19	696 0.8×	981 2.2×	985 2.5×	58 0.3×	22 0.1×	29	2.1k
Nicholas Borcherding United States	28	773 0.9×	1.3k 2.9×	923 2.3×	84 0.4×	23 0.2×	77	2.7k
Barbara Jacobs United States	26	951 1.1×	1.1k 2.4×	611 1.5×	68 0.3×	21 0.1×	43	2.0k
Til Menge Germany	26	445 0.5×	367 0.8×	267 0.7×	148 0.7×	34 0.2×	46	1.9k
Antonios Bayas Germany	19	301 0.3×	216 0.5×	210 0.5×	77 0.3×	37 0.3×	52	1.2k

Countries citing papers authored by Jahan S. Khalili

Since Specialization

Citations

This map shows the geographic impact of Jahan S. Khalili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jahan S. Khalili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jahan S. Khalili more than expected).

Fields of papers citing papers by Jahan S. Khalili

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jahan S. Khalili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jahan S. Khalili. The network helps show where Jahan S. Khalili may publish in the future.

Co-authorship network of co-authors of Jahan S. Khalili

This figure shows the co-authorship network connecting the top 25 collaborators of Jahan S. Khalili. A scholar is included among the top collaborators of Jahan S. Khalili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jahan S. Khalili. Jahan S. Khalili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jianxiang, Junyuan Qi, Ping Li, et al.. (2023). GNC-038, a tetra-specific antibody, in patients with R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia: A phase 1 study design and rationale.. Journal of Clinical Oncology. 41(16_suppl). TPS2668–TPS2668. 4 indexed citations

Tsai, Tsung-I, Jahan S. Khalili, Mark Gilchrist, et al.. (2022). ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern. Antiviral Research. 199. 105271–105271. 14 indexed citations

Khalili, Jahan S., et al.. (2020). Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19. Journal of Medical Virology. 92(7). 740–746. 253 indexed citations

Park, Jungsun, Amjad H. Talukder, Seon Ah Lim, et al.. (2017). SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity. Cancer Immunology Research. 5(8). 618–629. 24 indexed citations

Li, Suyan, Peeyush Kumar T, Timo Kirschstein, et al.. (2017). Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior. Cell Research. 28(2). 221–248. 80 indexed citations

Bradley, Sherille D., Zeming Chen, Brenda Melendez, et al.. (2015). BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunology Research. 3(6). 602–609. 124 indexed citations

Brown, Wells S., Jahan S. Khalili, Tania Rodríguez-Cruz, Gregory Lizée, & Bradley W. McIntyre. (2014). B-Raf Regulation of Integrin α4β1-mediated Resistance to Shear Stress through Changes in Cell Spreading and Cytoskeletal Association in T Cells. Journal of Biological Chemistry. 289(33). 23141–23153. 13 indexed citations

Khalili, Jahan S., Patrick Hwu, & Gregory Lizée. (2013). Forging a link between oncogenic signaling and immunosuppression in melanoma. OncoImmunology. 2(2). e22745–e22745. 7 indexed citations

Khalili, Jahan S., Xiaoxing Yu, Ji Wang, et al.. (2012). Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11 -Dependent Manner. Clinical Cancer Research. 18(16). 4345–4355. 112 indexed citations

10.

Joseph, Richard W., Ulas D. Bayraktar, Tae Kon Kim, et al.. (2012). Vitamin D receptor upregulation in alloreactive human T cells. Human Immunology. 73(7). 693–698. 34 indexed citations

11.

Khalili, Jahan S., Russell W. Hanson, & Zoltán Szállási. (2012). In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census. OncoImmunology. 1(8). 1281–1289. 19 indexed citations

12.

Griewank, Klaus, Xiaoxing Yu, Jahan S. Khalili, et al.. (2012). Genetic and molecular characterization of uveal melanoma cell lines. Pigment Cell & Melanoma Research. 25(2). 182–187. 92 indexed citations

13.

Rodríguez-Cruz, Tania, Shujuan Liu, Jahan S. Khalili, et al.. (2011). Natural Splice Variant of MHC Class I Cytoplasmic Tail Enhances Dendritic Cell-Induced CD8+ T-Cell Responses and Boosts Anti-Tumor Immunity. PLoS ONE. 6(8). e22939–e22939. 20 indexed citations

14.

Li, Dan, Yufeng Li, Jessica Hernández-Rodríguez, et al.. (2010). Lovastatin Inhibits T-cell Proliferation While Preserving the Cytolytic Function of EBV, CMV, and MART-1-specific CTLs. Journal of Immunotherapy. 33(9). 975–982. 9 indexed citations

15.

Voo, Kui Shin, Yui‐Hsi Wang, Fabio R. Santori, et al.. (2009). Identification of IL-17-producing FOXP3+ regulatory T cells in humans (89.1). The Journal of Immunology. 182(Supplement_1). 89.1–89.1. 28 indexed citations

16.

Wang, Yang, Dan Jones, Roland L. Bassett, et al.. (2009). Blocking LFA-1 Activation with Lovastatin Prevents Graft-versus-Host Disease in Mouse Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation. 15(12). 1513–1522. 28 indexed citations

17.

Long, S. Alice, et al.. (2006). Standardized analysis for the quantification of Vβ CDR3 T-cell receptor diversity. Journal of Immunological Methods. 317(1-2). 100–113. 27 indexed citations

18.

Noonan, Kimberly, William Matsui, Paolo Serafini, et al.. (2005). Activated Marrow-Infiltrating Lymphocytes Effectively Target Plasma Cells and Their Clonogenic Precursors. Cancer Research. 65(5). 2026–2034. 87 indexed citations

19.

Herling, Marco, Kaushali A. Patel, Jahan S. Khalili, et al.. (2005). TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia. 20(2). 280–285. 110 indexed citations

20.

Moore, Wayne V., Wenjiang Chu, Pei Tong, et al.. (2002). Prevention of Autoimmune Diabetes in the DRBB Rat by CD40/154 Blockade. Journal of Autoimmunity. 19(3). 139–145. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact